{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:49:33Z","timestamp":1772448573922,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.humpath.2021.11.005","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T11:04:49Z","timestamp":1637233489000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment\u2014a 5-year experience"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9603-6731","authenticated-orcid":false,"given":"Katrina","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Brocken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-801X","authenticated-orcid":false,"given":"Clinton D.","family":"Bahler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Alabd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael O.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.11.005_bib1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.eururo.2007.10.062","article-title":"First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer","volume":"53","author":"Blana","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.urology.2008.06.062","article-title":"Eight years' experience with high- intensity focused ultrasonography for treatment of localized prostate cancer","volume":"72","author":"Blana","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2021.11.005_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3816\/CGC.2005.n.031","article-title":"Prostate cancer therapy with high-intensity focused ultrasound","volume":"4","author":"Gardner","year":"2005","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2021.11.005_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/end.2000.14.519","article-title":"Transrectal high-intensity focused ultra- sound: minimally invasive therapy of localized prostate cancer","volume":"14","author":"Gelet","year":"2000","journal-title":"J Endourol"},{"key":"10.1016\/j.humpath.2021.11.005_bib5","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.juro.2007.08.014","article-title":"Phase I\/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer","volume":"178","author":"Koch","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0094-0143(05)70195-6","article-title":"Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy","volume":"26","author":"Bostwick","year":"1999","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.humpath.2021.11.005_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5858\/2007-131-360-DOPCAT","article-title":"Diagnosis of prostatic carcinoma after therapy","volume":"131","author":"Bostwick","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2021.11.005_bib8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/00000478-199910000-00002","article-title":"Diagnosis of prostate cancer in needle biopsies after radiation therapy","volume":"23","author":"Cheng","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.11.005_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00000478-199907000-00008","article-title":"Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy","volume":"23","author":"Cheng","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.11.005_bib10","first-page":"107","article-title":"Histopathological changes induced by therapies in the benign prostate and prostate adenocarcinoma","volume":"22","author":"Petraki","year":"2007","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.humpath.2021.11.005_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000474677","article-title":"Morphology of tissue destruction induced by focused ultrasound","volume":"23","author":"Susani","year":"1993","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib12","first-page":"3346","article-title":"Effect of high-intensity focused ultrasound on human prostate cancer in\u00a0vivo","volume":"55","author":"Madersbacher","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2021.11.005_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1097-0045(19990401)39:1<41::AID-PROS7>3.0.CO;2-5","article-title":"High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study","volume":"39","author":"Beerlage","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.humpath.2021.11.005_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jcp.53.5.391","article-title":"Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate","volume":"53","author":"Van Leenders","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2021.11.005_bib15","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/pros.21154","article-title":"Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU)","volume":"70","author":"Biermann","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.humpath.2021.11.005_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jclinpath-2011-200460","article-title":"Prostatic needle biopsies following primary high-intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue","volume":"65","author":"Ryan","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2021.11.005_bib17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00345-015-1561-0","article-title":"Histological outcomes after focal high-intensity focused ultrasound and cryotherapy","volume":"33","author":"Shah","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5489\/cuaj.3918","article-title":"Assessment of histopathological features of needle biopsy in recurrent prostate cancer following salvage high-intensity focused ultrasound","volume":"10","author":"Billia","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.humpath.2021.11.005_bib19","first-page":"125","article-title":"Classification of prostatic carcinomas","volume":"50","author":"Gleason","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.humpath.2021.11.005_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0046-8177(92)90108-F","article-title":"Histologic grading of prostate cancer: a perspective","volume":"23","author":"Gleason","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.11.005_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-5347(17)59889-4","article-title":"Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging","volume":"111","author":"Gleason","year":"1974","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1442-2042.1995.tb00450.x","article-title":"High intensity focused ultrasound for benign prostatic hyperplasia","volume":"2","author":"Uchida","year":"1995","journal-title":"Int J Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib23","doi-asserted-by":"crossref","unstructured":"Mulligan ED, Lynch TH, Mulvin D, Greene D, Smith JM, Fitzpatrick JM. High-intensity focused ultrasound in the treatment of benign prostatic hyperplasia. Br J Urol 1997;79:177\u2013180.","DOI":"10.1046\/j.1464-410X.1997.03286.x"},{"key":"10.1016\/j.humpath.2021.11.005_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1464-410X.1997.03286.x","article-title":"High-intensity focused ultrasound in the treat- ment of benign prostatic hyperplasia","volume":"79","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib25","first-page":"179","article-title":"High-intensity focused ultrasound in prostate cancer: results after 3 years","volume":"4","author":"Chaussy","year":"2000","journal-title":"Mol Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1442-2042.2006.01272.x","article-title":"Five years experience of transrectal high-intensity focused ultrasound using using the Sonable device in treatment of localized prostate cancer","volume":"13","author":"Uchida","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.urology.2003.09.020","article-title":"High intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience","volume":"63","author":"Blana","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2021.11.005_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11934-003-0077-0","article-title":"High the status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection","volume":"4","author":"Chaussy","year":"2003","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.humpath.2021.11.005_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.pcan.4500901","article-title":"High-intensity focused ultrasound therapy for clinically localized prostate cancer","volume":"9","author":"Lee","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.humpath.2021.11.005_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.eururo.2006.04.012","article-title":"Control of prostate cancer by transrectal HIFU in 227 patients","volume":"51","author":"Poissonnier","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib31","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1097\/01.ju.0000124880.35944.58","article-title":"Transreactal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study","volume":"171","author":"Vallancien","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/089277903322518699","article-title":"High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study","volume":"17","author":"Th\u00fcroff","year":"2003","journal-title":"J Endourol"},{"key":"10.1016\/j.humpath.2021.11.005_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mrm.21124","article-title":"Real-time methods for treatment of mobile organs by MRI-controlled high-intensity focused ultrasound","volume":"57","author":"de Senneville","year":"2007","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.humpath.2021.11.005_bib34","doi-asserted-by":"crossref","first-page":"283e9","DOI":"10.1097\/MOU.0b013e32832a2c4a","article-title":"Targeted focal therapy for prostate cancer: a review","volume":"19","author":"Hou","year":"2009","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib35","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/cncr.20243","article-title":"Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate","volume":"100","author":"Arora","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2021.11.005_bib36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.eururo.2014.08.079","article-title":"Multifocality and prostate cancer detections by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology","volume":"67","author":"Le","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2021.11.005_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2021.11.005_bib38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/pcan.2014.55","article-title":"Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images","volume":"18","author":"Abd-Alazeez","year":"2015","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.humpath.2021.11.005_bib39","doi-asserted-by":"crossref","first-page":"425.e1","DOI":"10.1016\/j.urolonc.2015.05.021","article-title":"Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy","volume":"33","author":"Muller","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2021.11.005_bib40","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.ijrobp.2011.11.030","article-title":"Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study","volume":"82","author":"Arrayeh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:29Z","timestamp":1758645569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721001945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":40,"alternative-id":["S0046817721001945"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.11.005","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment\u2014a 5-year experience","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}